PROMO!First order? Get 10% OFF with this code: 1storder
PROMO!First order? Get 10% OFF with this code: 1storder
<ú<ø € EUR0.00 Cart
Home / BPC-157 / BPC-157 Thymosin Beta-4 Capsules

BPC-157 Thymosin Beta-4 Capsules

BPC-157 Thymosin Beta-4 capsules represent a convenient and promising approach for enhancing tissue repair, reducing inflammation, and supporting overall recovery.

60 CAPSULES Per Bottle | 500mcg BPC-157 & 500mcg Thymosin Beta 4 Per Capsule 

Price: 157.77

SKU PW-BPC-Thymosin-B4-Capsules
Categories , ,
 Guaranteed High Purity +99% Pure
 New Customer Discount (code: 1storder) Get 10% off your first order
Description

Buy BPC-157 Thymosin Beta-4 Capsules In Europe

Looking to order B7-33 Pre-Mixed Peptide in Europe online? Look no further than Peptide Shop Europe (Peptide Shop Europe).

We supply top quality B7-33 Pre-Mixed Peptide in Europe for research and laboratory use. Our ready-to-use B7-33 liquid peptide comes pre-mixed, cold-chain shipped, and includes full COA documentation.

Researchers across the EU purchase B7-33 Pre-Mixed Peptide from Germany, France, UK and beyond with 48H dispatch from our EU warehouse. Whether you want to buy B7-33 liquid peptide Europe, shop pre-mixed B7-33 UK, get B7-33 peptide Germany, or find a relaxin analogue research peptide, we’ve got you covered.

Peptide Shop Europe is your trusted source to stock up on B7-33 Pre-Mixed in Europe. Skip the mixing and get consistent results with our pre-mixed B7-33 peptide solution — in stock now for fast EU delivery.

BPC-157 Thymosin Beta-4 Capsules are an oral combination product containing the investigational compounds BPC-157 and Thymosin Beta-4 (TB4) or a TB4-derived fragment, depending on the manufacturer’s formulation. These capsules are marketed by some manufacturers for research or other manufacturer-specified purposes, but neither BPC-157 nor Thymosin Beta-4 has been approved by major regulatory authorities for routine therapeutic use. (U.S. Food and Drug Administration)

BPC-157 is a synthetic peptide derived from a gastric protein fragment, while Thymosin Beta-4 is a naturally occurring protein involved in cellular processes such as cell migration and tissue repair. Most published research has evaluated these compounds separately, primarily in laboratory and animal studies, and there is currently no high-quality clinical evidence supporting the combined oral formulation in humans. (Form Laboratories)


What Are BPC-157 Thymosin Beta-4 Capsules?

BPC-157 Thymosin Beta-4 Capsules are manufacturer-prepared oral capsules containing predetermined amounts of BPC-157 and Thymosin Beta-4 or a related peptide fragment. Product composition, concentration, and intended use vary depending on the manufacturer.

Common characteristics include:

  • Oral capsule formulation
  • Combination of BPC-157 and Thymosin Beta-4
  • Manufacturer-labeled strength
  • Quality-controlled production
  • Batch and lot identification
  • Available in different capsule counts depending on the supplier

Features of BPC-157 Thymosin Beta-4 Capsules

Key product features may include:

  • Convenient oral capsule format
  • Pre-measured peptide content
  • Clearly labeled concentration
  • Quality-controlled manufacturing
  • Secure packaging for product protection
  • Manufacturer-specific storage recommendations
  • Available in various strengths and package sizes

Research Background of BPC-157 Thymosin Beta-4 Capsules

BPC-157 has been investigated in experimental studies involving gastrointestinal tissue, tendons, ligaments, blood vessels, and connective tissue. Thymosin Beta-4 has been studied for its role in cell migration, angiogenesis, tissue remodeling, and wound healing. Most available evidence comes from laboratory and animal research rather than completed human clinical trials.

Although these compounds are frequently discussed together, published scientific literature does not currently demonstrate clinical benefits of combining BPC-157 with Thymosin Beta-4 in capsule form. Their safety and effectiveness for routine medical use remain unestablished. (Condor Research)


Potential Research Applications of BPC-157 Thymosin Beta-4 Capsules

Research involving these investigational compounds has explored areas such as:

  • Tissue repair biology
  • Tendon and ligament research
  • Wound-healing studies
  • Gastrointestinal biology
  • Angiogenesis research
  • Cell migration studies
  • Laboratory and scientific investigations

These research areas remain experimental and should not be interpreted as approved medical uses. (Form Laboratories)


Storage Guidelines for BPC-157 Thymosin Beta-4 Capsules

To help preserve product quality:

  • Store according to the manufacturer’s instructions.
  • Keep the container tightly closed.
  • Store in a cool, dry place away from direct sunlight.
  • Protect from excessive heat and moisture.
  • Do not use if the packaging is damaged or the safety seal is broken.
  • Keep out of the reach of children.

Always follow the storage recommendations provided on the product label.


Safety Information for BPC-157 Thymosin Beta-4 Capsules

Important precautions include:

  • Use only according to the manufacturer’s labeling.
  • Do not use if the product packaging has been compromised.
  • Follow all storage and handling recommendations.
  • Consult a qualified healthcare professional regarding product suitability.
  • Discontinue use and seek medical advice if unexpected reactions occur.

Both BPC-157 and Thymosin Beta-4 remain investigational compounds, and their safety and effectiveness for routine therapeutic use have not been established by major regulatory authorities.


Disposal of BPC-157 Thymosin Beta-4 Capsules

After use or when expired:

  • Dispose of the product according to local regulations.
  • Do not use expired capsules.
  • Discard damaged containers appropriately.
  • Follow local pharmaceutical waste disposal requirements.
  • Keep unused products safely stored until disposal.

Frequently Asked Questions About BPC-157 Thymosin Beta-4 Capsules

What are BPC-157 Thymosin Beta-4 Capsules?

BPC-157 Thymosin Beta-4 Capsules are an oral combination product containing the investigational compounds BPC-157 and Thymosin Beta-4 or a related peptide fragment, depending on the manufacturer’s formulation. (U.S. Food and Drug Administration)

What are BPC-157 Thymosin Beta-4 Capsules used for?

BPC-157 Thymosin Beta-4 Capsules are generally intended for research or other manufacturer-specified purposes. Their combined use has not been established as an approved medical treatment. (Form Laboratories)

How should BPC-157 Thymosin Beta-4 Capsules be stored?

BPC-157 Thymosin Beta-4 Capsules should be stored according to the manufacturer’s recommendations, typically in a cool, dry location away from heat, moisture, and direct sunlight.


 


ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.

DISCLAIMER: Products are supplied for research purposes only and are not intended to diagnose, treat, cure, or prevent any disease.